CONTACT US
Home > Browse by topic > Drug Design

Drug Design Expert Witnesses

Drug design disputes in complex commercial litigation typically center on patent validity, licensing, and regulatory questions involving how a pharmaceutical compound was designed and optimized, arising when companies disagree over whether a claimed drug design mechanism is novel, whether licensed drug design technology was used as permitted, or whether disclosed research data support a patent or regulatory claim. These disputes surface in pharmaceutical patent litigation over small molecule and biologic drug design, in licensing disputes over the scope of permitted use for computational drug design platforms and chemical libraries, and in disputes over whether preclinical drug design data accurately support a company's scientific or regulatory representations. Because drug design mechanisms are technical enough that reasonable medicinal chemists can characterize the same experimental data differently, the central issue is typically whether the underlying drug design evidence supports the scientific, patent, or regulatory position a party has taken.

A drug design expert helps attorneys evaluate that evidence by applying accepted medicinal chemistry and computational drug design methods to the mechanism at issue. That might mean assessing whether prior art drug design research anticipates or renders obvious a claimed compound or design methodology, evaluating whether a licensee's use of a computer-aided drug design platform stayed within the scope of a license agreement, or analyzing whether preclinical drug design data support a company's scientific claims. This analysis supports positions on patent validity, breach of license terms, and regulatory compliance, giving attorneys a scientifically grounded basis for litigation strategy.

Drug design cases benefit from experts whose specific research background, whether medicinal chemistry, computer-aided drug design, or structure-activity relationship analysis, matches the precise drug design mechanism at issue rather than drug design in general terms. Round Table Group's drug design network includes medicinal chemists, biochemists, and bioinformatics researchers with published work spanning drug design, protein physics, and toxicology, several of whom have testified in patent and licensing matters. With more than 75,000 expert searches completed for litigators, we help attorneys match a case's specific drug design question to an expert whose scientific credentials will withstand scrutiny. Let us help you find the right drug design expert for your case by calling us at (202) 908-4500.

Here are a few of our favorite Drug Design Expert Witnesses:

I have 25 years of experience, and specialize in the field of medicinal chemistry with specific knowledge in the areas of drug design, peptides and structure activity relationships. I have published on such topics as opioid agonists and antagonists, thrombin inhibitors and anticoagulants and protein structure modeling. I have testified on angiotensin converting enzyme inhibitors, stereochemistry and structure-activity relationships.

 

I have 15 years of experience, and specialize in the field of medicinal chemistry with specific knowledge in the areas of drug design, kinases and G protein-coupled receptors (GPCR). I have published on such topics as kinase, GPCR inhibitors, approaches to file enhancement and chemical methodology development.

 

I have 25 years of experience and specialize in the field of molecular biology, with specific knowledge of protein crystallography, transcription and structure-based drug design. I have published on such topics as structural studies of aminoacyl-tRNA synthetase, structural studies of transcription complexes, and structural studies of antibiotics targeting bacterial RNA polymerase.

 

I have 22 years of experience and specialize in the field of bioinformatics, with specific knowledge of computational chemistry, computer-aided drug design and molecular biophysics. I have published on such topics as drug design, protein physics and computational chemistry.

 

I have 20 years of experience and specialize in the field of medicinal chemistry, with specific knowledge reas of drug design, drug delivery, and diagnostic and sensor. I have published on such topics as organic chemistry, medicinal chemistry and sensor.

 

Your Case Deserves The Best Drug Design Expert Witnesses

Registered icon

The right expert witnesses and consulting experts can make your case. That’s why we have spent so many hours over the past quarter century making sure our clients have just the right expert team — whether one expert or many, early-stage advice or expert reports and testimony. Across over 50,000 expert search assignments, we have honed a unique, customized approach to identifying, analyzing and connecting with expert talent so you can focus on winning your case.

I have 30 years of experience and specialize in the field of medicinal chemistry, with specific knowledge of drug design, nucleosides and enzyme inhibitors. I have published on such topics as anti-infectious agents and enzyme inhibitors. I have testified on antiviral nucleosides.

 

I have 20 years of experience and specialize in the field of biochemistry, with specific knowledge of drug discovery, pharmaceutical chemistry and computational chemistry. I have published on such topics as the mechanism of action of diphtheria toxin, chemistry of uric acid oxidation and the computational modeling of biochemical processes.

 

I have 30 years of experience, and specialize in the field of drug design and development with specific knowledge in the areas of medicinal chemistry, cancer drugs and antibacterial drugs. I have published on such topics as drug synthesis, cancer drug development and antibacterial drug development.

 

I have 27 years of experience and specialize in the field of synthetic organic chemistry, with specific knowledge of medicinal chemistry, drug design and anticancer agents. I have published on such topics as natural products total synthesis, anticancer drug mechanism of action and synthetic organic methodology.

 

I have 15 years of experience, and specialize in the field of drug design and synthesis with specific knowledge in the areas of heparin, proteoglycans and sulfated polysaccharides, antibiotics, and anti-cancer agents. I have published on such topics as antibiotic resistance, design and synthesis of new antibacterial agents and design, synthesis and evaluation heparinoids, and heparin-like sulfated polysaccharides.

 

I have 30 years of experience, and specialize in the field of drug design with specific knowledge in the areas of computational chemistry, docking, structural biology, molecular dynamics, and nuclear receptors. I have published on such topics as ligand protein and peptide energetics and dynamics, solvent structure, potential energy function derivation and quantum studies of gland binding.

 

I have 25 years of experience and specialize in the field of biochemistry, with specific knowledge of molecular biology, toxicology and toxic metal removal. I have published on such topics as phthalate ester toxicity, trace metal homeostasis and technology for toxic metal removal and recovery. I have patented a technology for the selective removal and/or recovery of toxic and precious metals.

 

I have 25 years of experience, and specialize in the field of drug discovery and development with specific knowledge in the areas of anti-infectious, anticancer and nutraceuticals. I have published on such topics as synthesis, synthetic-aperture radar (SAR), and application of biologically active small molecule heterocycles, discovery to preclinical studies on antimycotic agents effective against systemic and deep-seated mycosis and isolation and identification of the active ingredients of medicinal plants.

 

I have 31 years of experience and specialize in the field of medicinal chemistry, with specific knowledge of drug design and total synthesis of natural products. I have published on such topics as design and development of new kinase inhibitors as chemotherapeutic agents, PET imaging of chemotherapeutic agents and synthetic natural products.

 

I have 40 years of experience and specialize in the field of cancer drug design, with specific knowledge of chemotherapy, photodynamic therapy and sonodynamic therapy. I have published on such topics as drug design and mechanism of action.

 

I have 4 years of experience, and specialize in the field of preclinical drug discovery with specific knowledge in the areas of drug design, drug metabolism and biochemical toxicology. I have published on such topics as melanoma, prodrug design and development and biochemical toxicology.

 

I have 35 years of experience and specialize in the field of medicinal chemistry, with specific knowledge of drug development, biomedical imaging and cancer chemotherapeutics. I have published on such topics as radioimaging agents, hormonal therapeutics and drug development.

 

I have 40 years of experience, and specialize in the field of drug discovery and development with specific knowledge in the areas of medicinal chemistry, preclinical development and organic chemistry. I have published on such topics as heart failure drugs, neuroscience drugs and gastrointestinal drugs. I have testified on proton pump inhibitors and sleep agents via deposition.

 

I have 22 years of experience and specialize in the field of organic chemistry with specific knowledge in the areas of organic synthesis, peptide synthesis and molecular modeling. I have published on such topics as total synthesis of natural products, design, synthesis and evaluation of enzyme inhibitors, and synthesis of non-proteinogenic amino acids. I have testified on patent infringement, interpretation of patent specifications and definition of organic chemistry terminology.

 

Put Our Drug Design Expert Network to Work for You

Registered icon

Our huge network of experts – eminent university professors and practitioners who have achieved renown as thought leaders in their fields – combined with unparalleled research capabilities puts the experts you need at your disposal when and where you need them.

If you’re a litigator or general counsel, we want to put this network to work for you and your clients. Let us know how we can help by calling us at (202) 908-4500 or filling out the form on this page. We’re so confident you’ll love what we do that unless you retain an expert we present there’s no charge!

Questions Attorneys Ask About Drug Design Expert Witnesses:

A drug design expert typically becomes necessary in pharmaceutical patent litigation over small molecule or biologic drug design, licensing disputes over the permitted scope of use for computational drug design platforms, and disputes over whether preclinical drug design data support a company's scientific or regulatory representations.

GET STARTED FINDING THE RIGHT EXPERT WITNESS

Spend your time working with your experts, not searching for them! We're here to de-stress the process of having a great expert witness team so that it’s easy to have the right experts every time. We'll conduct a quick but thorough search and deliver a roster of top candidates for you to review. There's no charge for the custom search — you pay only the hourly rate if you retain one of our experts.

  • This field is for validation purposes and should be left unchanged.

Or call 202-908-4500 or email us.